Fucoidan was also reported to be an antitumor compound inhibiting migration, invasion and MMP-2/-9 activities in human fibrosarcoma cells (HT1080), human lung cancer cells (A549) and mouse hepatocarcinoma cells lines (Hca-F) [52,53,54]. This evidence concerns the gene MMP2 and lung carcinoma.